Natixis’s Savara SVRA Stock Holding History

Natixis’s Portfolio SVRA Stock Details SVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20	Closed	-$56	–	1164
2025 Q1	$56	Buy	+20	New	+$55	﹤0.01%	955

Other funds holding SVRA

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Natixis's SVRA Position: Q2 2025 in Review

Natixis sold out of Savara (SVRA) in Q2 2025, closing a stake of 20 shares — an estimated $56 sold.

Natixis first reported a position in SVRA in Q1 2025 and held it in 1 quarter. The position peaked at $56 in Q1 2025. 122 funds tracked by Wall St. Rank hold SVRA as of Q2 2025.

Natixis reported no remaining Savara position as of Q2 2025 after selling out during the quarter.
Natixis sold 20 Savara shares in Q2 2025, an estimated $56.
Natixis first reported a position in Savara in Q1 2025 and held it in 1 quarter.
Natixis's Savara position peaked at $56 in Q1 2025.
122 funds tracked by Wall St. Rank held Savara as of Q2 2025.

Based on Natixis's 13F filing for Q2 2025, filed 13 Aug 2025.